Business Context and Reporting Period
Company: Flotek Industries, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2019 (Signed March 4, 2019)
Key Event: Completion of the divestiture of Florida Chemical Company, LLC ("FCC") to Archer-Daniels-Midland Company ("ADM") effective February 28, 2019.
Key Financial Metrics
This filing is a current report regarding corporate events and does not contain standard periodic financial metrics such as revenue, profit, cash flow, margins, or debt levels for the reporting period. The filing references unaudited pro forma condensed consolidated financial statements reflecting the divestiture, which are attached as Exhibit 99.2 but are not detailed within the text of this summary.
Material Changes
- Asset Disposition: Completed the sale of all membership interests in FCC to ADM pursuant to a Share Purchase Agreement dated January 10, 2019.
- Supply Agreements: In connection with the divestiture, Florida Chemistry, LLC (a subsidiary) entered into a Terpene Supply Agreement and a Citrus Burst Supply Agreement with FCC.
- Executive Departure: Joshua A. Snively's employment was terminated without cause, effective February 28, 2019, in connection with the divestiture. He ceased to be an officer of the Company.
Guidance, Outlook, and Management Commentary
- Management Commentary: The departure of Mr. Snively was not due to any disagreement regarding the Company's operations, policies, or practices.
- Compensatory Arrangements: In connection with Mr. Snively's departure, the Company accelerated the vesting of all his outstanding equity incentive awards.
- Disclosure: A press release announcing the divestiture was issued on March 1, 2019 (Exhibit 99.1).
- Outlook: The filing text does not provide specific forward-looking guidance or outlook beyond the completion of the transaction.
Investor Verification Checklist
- Review Exhibit 99.2 for the unaudited pro forma condensed consolidated financial statements to understand the financial impact of the FCC divestiture.
- Examine Exhibit 2.1 (Share Purchase Agreement) for specific terms of the sale to ADM, noting that portions were omitted for confidential treatment.
- Verify the terms of the new Supply Agreements (Terpene and Citrus Burst) referenced in Item 1.01 to assess ongoing operational relationships with FCC.
- Confirm the details of the accelerated equity vesting for the departing officer in the referenced Employment Agreement (Exhibit 10.1 from March 22, 2018).